24.12
Heartflow Inc stock is traded at $24.12, with a volume of 886.77K.
It is down -1.99% in the last 24 hours and down -30.91% over the past month.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.
See More
Previous Close:
$24.61
Open:
$24.98
24h Volume:
886.77K
Relative Volume:
0.61
Market Cap:
$2.08B
Revenue:
$191.42M
Net Income/Loss:
$-111.83M
P/E Ratio:
-18.20
EPS:
-1.3253
Net Cash Flow:
$-76.77M
1W Performance:
-3.05%
1M Performance:
-30.91%
6M Performance:
-25.00%
1Y Performance:
+0.00%
Heartflow Inc Stock (HTFL) Company Profile
Name
Heartflow Inc
Sector
Industry
Phone
650-241-1221
Address
135 MAIN STREET, SUITE 1000, SAN FRANCISCO
Compare HTFL vs VEEV, BTSG, HQY, TEM, TXG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
HTFL
Heartflow Inc
|
24.12 | 2.08B | 191.42M | -111.83M | -76.77M | -1.3253 |
|
VEEV
Veeva Systems Inc
|
186.24 | 30.25B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
72.91 | 14.31B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
HQY
Healthequity Inc
|
94.64 | 7.91B | 1.34B | 230.70M | 440.96M | 2.6695 |
|
TEM
Tempus Ai Inc
|
42.69 | 7.69B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
TXG
10 X Genomics Inc
|
46.27 | 5.87B | 638.78M | -22.66M | 122.18M | -0.1744 |
Heartflow Inc Stock (HTFL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-28-26 | Initiated | Wells Fargo | Overweight |
| Sep-02-25 | Initiated | Canaccord Genuity | Buy |
| Sep-02-25 | Initiated | JP Morgan | Overweight |
| Sep-02-25 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-02-25 | Initiated | Piper Sandler | Overweight |
| Sep-02-25 | Initiated | Stifel | Buy |
View All
Heartflow Inc Stock (HTFL) Latest News
Enterprise value to EBIT forward of Heartflow, Inc. – NASDAQ:HTFL - TradingView
Form 4 Heartflow Inc For: 24 July By Investing.com - Investing.com Canada
Heartflow's Q1 2026 Beat: Is This the Turning Point for HTFL - Kavout | AI
Heartflow, Inc. (HTFL) stock price, news, quote and history - Yahoo Finance Australia
Heartflow, Inc. (HTFL) Stock Price, News, Quote & History - Yahoo! Finance Canada
Heartflow to Report Second Quarter 2026 Financial Results on August 13, 2026 - AI Magazine
HeartFlow CFO Vikram Verghese Purchases 22,522 Shares and Receives Stock Options in Open Market Deal - Kalkine Media
Form 4 Heartflow Inc For: 23 July By Investing.com - Investing.com Nigeria
Form 4 Heartflow Inc For: 23 July - Investing.com India
Heartflow schedules Aug. 13 call on AI coronary technology - Stock Titan
Lobbying Update: $100,000 of HEARTFLOW INC. lobbying was just disclosed - Quiver Quantitative
Heartflow Director Timothy Barabe Purchases 5,000 Shares and Receives Stock Options in July 2026 Insider Transaction - Kalkine Media
Frontier tech research, news & data - MLQ.ai
Heartflow Inc. (HTFL) Retreats 4.2% as Technical Support Levels Come into FocusInsider Selling Alerts - dars.gov.et
Heartflow Chief Medical Officer Campbell Rogers disposes of 9,219 common shares worth $237,077.68 - Bitget
Form 4 Heartflow Inc For: 17 July By Investing.com - Investing.com Nigeria
Heartflow CMO Rogers Campbell sells $237,112 in stock - Investing.com
Heartflow (HTFL) CMO option exercise and 9,219-share sale under 10b5-1 plan - Stock Titan
Heartflow CMO Rogers Campbell sells $237,112 in stock By Investing.com - Investing.com South Africa
Heartflow, Inc. Common Stock (NASDAQ: HTFL) Stock Price, News & Analysis - Kalkine
Stifel reiterates HeartFlow stock rating after cardiology meeting By Investing.com - Investing.com Nigeria
Form 144 Heartflow For: 15 July By Investing.com - Investing.com Nigeria
Campbell D. Rogers plans 9,219-share HTFL stock sale on NASDAQ - Stock Titan
What Does the HeartFlow CEO's Sale of Over 20,000 Company Shares Mean for Investors? - The Motley Fool
Stifel reiterates HeartFlow stock rating after cardiology meeting - Investing.com
What Does the HeartFlow CEO's Sale of Over 20,000 Company Shares Mean for Investors? - The Motley Fool
Heartflow Inc. (HTFL) Edges Higher Amid Steady Trading – Key Levels to WatchExtension Target - dars.gov.et
HeartFlow Inc (HTFL) CEO John Farquhar Sells 22,562 Shares - GuruFocus
Heartflow CEO John Farquhar sells $626,095 in company stock By Investing.com - Investing.com India
Heartflow's AI-Driven Upside: Why CEO Sales Aren't the Full Story - Kavout | AI
Heartflow CEO John Farquhar sells $626,095 in company stock - Investing.com UK
Form 4 Heartflow Inc For: 13 July By Investing.com - Investing.com Nigeria
[Form 4] Heartflow, Inc. Insider Trading Activity - Stock Titan
William Blair Maintains Heartflow(HTFL.US) With Buy Rating - Moomoo
Heartflow Inc (HTFL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
HeartFlow Sees Insider Stock Selling - simplywall.st
HeartFlow's AI platform drives strong growth an... - Pluang
HeartFlow: A Premium AI Diagnostics Story (NASDAQ:HTFL) - Seeking Alpha
Form 4 Heartflow Inc For: 10 July By Investing.com - Investing.com South Africa
Heartflow (HTFL) director William C. Weldon exercises stock options for 51,369 shares - Stock Titan
Form 144 Heartflow For: 10 July By Investing.com - Investing.com South Africa
[144] Heartflow, Inc. SEC Filing - Stock Titan
Heartflow Inc Stock (HTFL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Heartflow Inc Stock (HTFL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Verghese Vikram | Chief Financial Officer |
Jul 21 '26 |
Option Exercise |
2.22 |
22,522 |
49,999 |
233,376 |
| BARABE TIMOTHY C | Director |
Jul 17 '26 |
Option Exercise |
19.00 |
5,000 |
95,000 |
184,521 |
| Rogers Campbell | Chief Medical Officer |
Jul 15 '26 |
Option Exercise |
19.00 |
9,219 |
175,161 |
97,950 |
| Rogers Campbell | Chief Medical Officer |
Jul 15 '26 |
Sale |
25.72 |
9,219 |
237,113 |
88,731 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):